How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Slicing bytes copies. On a small payload nobody notices, but slice a large packet or image buffer in a loop and the copies ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

The US-China race for artificial intelligence dominance has entered a new phase: using AI to build better AI. Leading AI companies in the United States and China are increasingly focused on deploying ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

A recursive JSON-to-relational conversion engine written in Python that analyzes semi-structured JSON data at runtime, infers a relational schema, generates PostgreSQL tables, creates ...

What vector and graph databases actually do, why AI agents made both matter, which vendors offer UK hosting, and when the ...

CRESSim-Neo is a C++17 simulation engine with optional Python bindings. Third-party C++ dependencies (including Diligent Engine, pybind11, and GLFW) are tracked as in-tree git submodules; a normal ...